162 related articles for article (PubMed ID: 33005852)
1. S6 ribosomal protein phosphorylation is associated with malignancy of intraductal papillary mucinous neoplasm of the pancreas.
Hirashita T; Hirashita Y; Iwashita Y; Endo Y; Kiyonaga M; Matsumoto S; Hijiya N; Moriyama M; Murakami K; Inomata M
Ann Gastroenterol Surg; 2020 Sep; 4(5):571-579. PubMed ID: 33005852
[TBL] [Abstract][Full Text] [Related]
2. SLC2A1/GLUT1 expression in mural nodules of intraductal papillary mucinous neoplasm of the pancreas.
Oda Y; Aishima S; Shindo K; Fujino M; Mizuuchi Y; Hattori M; Miyazaki T; Tanaka M; Oda Y
Hum Pathol; 2017 Jul; 65():71-78. PubMed ID: 28412205
[TBL] [Abstract][Full Text] [Related]
3. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography in differential diagnosis of benign and malignant intraductal papillary-mucinous neoplasm of the pancreas.
Tomimaru Y; Takeda Y; Tatsumi M; Kim T; Kobayashi S; Marubashi S; Eguchi H; Tanemura M; Kitagawa T; Nagano H; Umeshita K; Wakasa K; Doki Y; Mori M
Oncol Rep; 2010 Sep; 24(3):613-20. PubMed ID: 20664965
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of 18-FDG PET/CT in Detecting Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Yamashita YI; Okabe H; Hayashi H; Imai K; Nakagawa S; Nakao Y; Yusa T; Itoyama R; Yama T; Umesaki N; Arima K; Miyata T; Chikamoto A; Baba H
Anticancer Res; 2019 May; 39(5):2493-2499. PubMed ID: 31092444
[TBL] [Abstract][Full Text] [Related]
5. Additional value of FDG PET/CT to contrast-enhanced CT in the differentiation between benign and malignant intraductal papillary mucinous neoplasms of the pancreas with mural nodules.
Takanami K; Hiraide T; Tsuda M; Nakamura Y; Kaneta T; Takase K; Fukuda H; Takahashi S
Ann Nucl Med; 2011 Aug; 25(7):501-10. PubMed ID: 21537945
[TBL] [Abstract][Full Text] [Related]
6. Comparison of International Consensus Guidelines versus 18-FDG PET in detecting malignancy of intraductal papillary mucinous neoplasms of the pancreas.
Pedrazzoli S; Sperti C; Pasquali C; Bissoli S; Chierichetti F
Ann Surg; 2011 Dec; 254(6):971-6. PubMed ID: 22076067
[TBL] [Abstract][Full Text] [Related]
7. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
[TBL] [Abstract][Full Text] [Related]
8. Glucose metabolic upregulation via phosphorylation of S6 ribosomal protein affects tumor progression in distal cholangiocarcinoma.
Fujinaga A; Hirashita T; Hirashita Y; Sakai K; Kawamura M; Masuda T; Endo Y; Ohta M; Murakami K; Inomata M
BMC Gastroenterol; 2023 May; 23(1):157. PubMed ID: 37193984
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of positron emission tomography (PET)/contrast-enhanced computed tomography (CE-CT) in discriminating between malignant and benign intraductal papillary mucinous neoplasms (IPMNs).
Ohta K; Tanada M; Sugawara Y; Teramoto N; Iguchi H
Pancreatology; 2017; 17(6):911-919. PubMed ID: 29033011
[TBL] [Abstract][Full Text] [Related]
10. The value of
Regenet N; Sauvanet A; Muscari F; Meunier B; Mariette C; Adham M; Moutardier V; Delpero JR; Regimbeau JM; Pessaux P; Paye F; Sa Cunha A; Ansquer C
J Visc Surg; 2020 Oct; 157(5):387-394. PubMed ID: 32005594
[TBL] [Abstract][Full Text] [Related]
11. Does PET with CT Have Clinical Utility in the Management of Patients with Intraductal Papillary Mucinous Neoplasm?
Roch AM; Barron MR; Tann M; Sandrasegar K; Hannaford KN; Ceppa EP; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
J Am Coll Surg; 2015 Jul; 221(1):48-56. PubMed ID: 26095551
[TBL] [Abstract][Full Text] [Related]
12. Systematic review of the utility of 18-FDG PET in the preoperative evaluation of IPMNs and cystic lesions of the pancreas.
Srinivasan N; Koh YX; Goh BKP
Surgery; 2019 May; 165(5):929-937. PubMed ID: 30577952
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical FAP Expression Reflects
Spektor AM; Gutjahr E; Lang M; Glatting FM; Hackert T; Pausch T; Tjaden C; Schreckenberger M; Haberkorn U; Röhrich M
J Nucl Med; 2024 Jan; 65(1):52-58. PubMed ID: 38167622
[TBL] [Abstract][Full Text] [Related]
14. The tumor-to-liver ratio of the standardized uptake value is a useful FDG-PET/CT parameter for predicting malignant intraductal papillary mucinous neoplasm of the pancreas.
Utsunomiya T; Ogawa K; Funamizu N; Sakamoto K; Watanabe J; Otani H; Kawaguchi N; Miyagawa M; Iwaki H; Takada Y
Ann Gastroenterol Surg; 2022 Sep; 6(5):695-703. PubMed ID: 36091311
[TBL] [Abstract][Full Text] [Related]
15. FDG-PET Findings of Intraductal Oncocytic Papillary Neoplasms of the Pancreas: Two Case Reports.
Kato T; Ikari S; Hirata K; Machida T; Nakamura H; Meguro T; Morita T; Takahashi T; Tamaki N; Horita S
Case Rep Gastroenterol; 2012 May; 6(2):415-24. PubMed ID: 22933987
[TBL] [Abstract][Full Text] [Related]
16. Searching for indicators of malignancy in pancreatic intraductal papillary mucinous neoplasms: the value of 18FDG-PET confirmed.
Baiocchi GL; Bertagna F; Gheza F; Grazioli L; Calanducci D; Giubbini R; Portolani N; Giulini SM
Ann Surg Oncol; 2012 Oct; 19(11):3574-80. PubMed ID: 22752369
[TBL] [Abstract][Full Text] [Related]
17. Use of F-18 fluorodeoxyglucose positron emission tomography with dual-phase imaging to identify intraductal papillary mucinous neoplasm.
Saito M; Ishihara T; Tada M; Tsuyuguchi T; Mikata R; Sakai Y; Tawada K; Sugiyama H; Kurosawa J; Otsuka M; Uchida Y; Uchiyama K; Miyazaki M; Yokosuka O
Clin Gastroenterol Hepatol; 2013 Feb; 11(2):181-6. PubMed ID: 23142206
[TBL] [Abstract][Full Text] [Related]
18. Possible additional value of 18FDG-PET in managing pancreas intraductal papillary mucinous neoplasms: preliminary results.
Baiocchi GL; Portolani N; Bertagna F; Gheza F; Pizzocaro C; Giubbini R; Giulini SM
J Exp Clin Cancer Res; 2008 Jun; 27(1):10. PubMed ID: 18577196
[TBL] [Abstract][Full Text] [Related]
19. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
[TBL] [Abstract][Full Text] [Related]
20. [Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas Showing High Accumulation of 18F-Fluorodeoxyglucose (FDG)--A Case Report].
Kubota M; Nishimura M; Nakatsuka R; Miyazaki S; Danno K; Motoori M; Matsuda C; Fujitani K; Iwase K
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2394-6. PubMed ID: 26805375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
